Rapidly Progressive Glomerulonephritis clinical trials

Explore recruiting rapidly progressive glomerulonephritis clinical trials.

Recruiting rapidly progressive glomerulonephritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Rapidly Progressive Glomerulonephritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Randomized, Double-Blind, Placebo-Controlled Study of Intravenously Administered ALE.F02 to Evaluate the Safety, Tolerability, Pharmacokinetics, and Renal Sparing in Antineutrophil Cytoplasmic Antibody Associated Vasculitis With Rapidly Progressive Glomerulonephritis

Czechia, Germany, Italy, Spain, Denmark, France +1 more

Therapeutic exploratory (Phase II) EU CTIS Study details

Rapidly Progressive Glomerulonephritis trials by city

Rapidly Progressive Glomerulonephritis in Toronto Rapidly Progressive Glomerulonephritis in Vancouver Rapidly Progressive Glomerulonephritis in Montreal Rapidly Progressive Glomerulonephritis in Calgary Rapidly Progressive Glomerulonephritis in Edmonton Rapidly Progressive Glomerulonephritis in Ottawa Rapidly Progressive Glomerulonephritis in Winnipeg Rapidly Progressive Glomerulonephritis in Quebec City Rapidly Progressive Glomerulonephritis in Hamilton Rapidly Progressive Glomerulonephritis in Kitchener Rapidly Progressive Glomerulonephritis in London Rapidly Progressive Glomerulonephritis in Halifax Rapidly Progressive Glomerulonephritis in New York Rapidly Progressive Glomerulonephritis in Los Angeles Rapidly Progressive Glomerulonephritis in Chicago Rapidly Progressive Glomerulonephritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease